Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
He is Proficient in overseeing and leading teams for running successful business operations
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Mindset disagrees with and denies the allegations set forth from Reunion.
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
Subscribe To Our Newsletter & Stay Updated